Adolescence to early adulthood transition in French severe asthmatic children treated with omalizumab

BACKGROUND

Transition from adolescence to early adulthood is a critical time for severe asthmatic children. Data regarding asthma care are lacking.

OBJECTIVES

To describe omalizumab (OMA) exposure and medical visits over the adolescent (16-17years (y)) to young adult (18-19y) period in asthma patients..

find the whole article here ==>https://doi.org/10.1183/13993003.congress-2022.2897

Authors
C.Taillé, M. Humbert, A. Bourdin, R. Niarra, C. Thonnelier, A. Lajoinie, A. Rigault, M. Molimard, et A. Deschildre.